Feature | May 12, 2014

Maquet Recalls Intra-Aortic Balloon Pumps Due to Potential Failure of Power Supply

Company says recall affects 12,360 IABP units sold globally

IABP, Datascope, Maquet, FDA recall

May 12, 2014 — Datascope Corp./Maquet initiated a voluntary worldwide field correction of some of its intra-aortic balloon pumps (IABPs) due to a potential mechanical failure of the fan assembly associated with the power supply. All customers that may have an IABP affected by this field correction have been notified. The company says there are about 12,360 affected units sold globally.

The firm received 106 reports of device malfunctions, which caused one death, involving its system 98/98XT, CS100, CS100i and CS300 IABPs. The firm determined that the fan assembly for the affected IABPs could contain a misshapen retaining ring. This retaining ring could separate within the fan assembly, causing the fan to stop rotating. This could result in the power supply overheating and the IABP would shut down without any warning. This device failure would cause the balloon to stop inflating and deflating. It may result in decreased blood flow to the heart and the rest of the body, difficulty in weaning the patient from cardiopulmonary bypass, and clotting or blockage of blood vessels to the intestines, kidneys, or legs. The possible long range consequences of this include organ injury or tissue damage, possibly leading to patient death.

The recalled systems were sold under the Datascope Corp. and include system 98/98XT (part numbers: 0998-00-0446-xx, 0998-UC-0446-xx, 0998-00- 0479-xx and 0998-UC-0479-xx), CS100/CS100i (Part Numbers: 0998-00-3013-xx, 0998-UC-3013-xx, 0998-UC-0446Hxx and 0998-UC-0479Hxx) and CS300 (part numbers:0998-00-3023-xx and 0998-UC-3023-xx).

The IABP is an electromechanical system used to inflate and deflate an intra-aortic balloon to provide temporary support to the left ventricle via the principle of counter pulsation.

Between Jan. 1, 2003, and June 30, 2011, specific System 98/98XT, CS100/CS100i and CS300 IABPs were manufactured with an affected fan assembly, or may have received an affected fan assembly during an upgrade/service of the IABP in the field. The affected IABP units were distributed in the United States and worldwide (in more than 100 countries). The affected IABP's can be identified by part and serial number. Each Maquet service representative has a list of the affected serial numbers and will check each affected part during the corrective action.

The affected system 98/98XT, CS100, CS100i and CS300 IABPs involved in the field correction can be used while waiting for parts and service. Customers should adhere to the instructions for use when using an affected IABP.

The U.S. Food and Drug Administration (FDA) has classified this action as a Class 1 recall. FDA defines Class 1 recalls as, "a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death." To date, there have been no reported patient injuries or deaths related to the power supply malfunction.

The corrective action associated with this recall is to provide a replacement fan assembly to all IABPs containing an affected fan assembly. A Maquet service representative will contact those facilities with affected IABP's to schedule corrective action and document this corrective action during a visit to the customer.

For additional information regarding this field correction, please contact the Technical Support Department at (800) 777-4222 and press 3 (Monday through Friday 8 a.m. – 6 p.m. EST).

For more information: www.fda.gov/MedicalDevices/NewsEvents/News/default.htm

Related Content

HeartWare, ENDURANCE2 trial, destination therapy, HVAS, HeartWare Ventricular Assist System
News | Ventricular Assist Devices (VAD)| August 11, 2015
HeartWare International Inc. announced that enrollment in the ENDURANCE2 destination therapy clinical trial has been...
Mayo Clinic, LVAD, study, heart failure, restrictive cardiomyopathy, RCM

Thoratec HeartMate II image courtesy of Thoratec

News | Ventricular Assist Devices (VAD)| August 07, 2015
Mayo Clinic is announcing results of a study on the effectiveness of left-ventricular assist devices (LVAD) in treating...
FDA, warning, LVADs, left ventricular assist devices, Thoratec, HeartMate II, HeartWare, HVAD
News | Ventricular Assist Devices (VAD)| August 06, 2015
The U.S. Food and Drug Administration (FDA) is alerting healthcare providers, patients and caregivers about serious...
HeartMate PHP, Thoratec, St. Jude medical

The HeartMate PHP (percutaneous heart pump) is the latest acute hemodynamic support technology released by Thoratec, which recently received CE mark in Europe. The PHP is currently in U.S.clinical trials.

Feature | Ventricular Assist Devices (VAD)| July 22, 2015
St. Jude Medical and Thoratec announced that the boards of directors of both companies have unanimously approved a...
Thoratec, HeartMate PHP. CE Mark approval, SHIELD I
Feature | Ventricular Assist Devices (VAD)| July 15, 2015
Thoratec announced that the HeartMate PHP (Percutaneous Heart Pump) received CE Mark approval, permitting sale in the...
Abiomed, U.S. headquarters expansion, Impella 2.5, RP, jobs
News | Ventricular Assist Devices (VAD)| July 09, 2015
During an event with Massachusetts Gov. Charlie Baker in June, Abiomed announced a major expansion of its U.S....
ECRI Institute, review, Impella RP, Abiomed
News | Ventricular Assist Devices (VAD)| June 11, 2015
ECRI Institute recently reviewed published data on Abiomed's Impella RP (Right Percutaneous) transcatheter ventricular...
UH Case Medical Center, Impella RP, first in Ohio, Abiomed, Mobile Learning Lab
News | Ventricular Assist Devices (VAD)| June 09, 2015
University Hospitals Case Medical Center physicians in the Harrington Heart & Vascular Institute were the first in...
Beaumont Hospital Royal Oak, Impella RP, right-side heart failure, Abiomed
News | June 04, 2015
Beaumont Hospital, Royal Oak is one of the first centers in the United States to use a new minimally invasive heart...
IABP, peer review, Maquet, Journal of Invasive Cardiology
Feature | June 01, 2015
Maquet Getinge Group announced the publication of a manuscript describing the exploration of the hemodynamic effects of...
Overlay Init